Sichuan Huiyu Pharmaceutical Hits Day Low at CNY 11.65 Amid Price Pressure

Sichuan Huiyu Pharmaceutical Co., Ltd. experienced a notable decline today, with its stock price dropping by 5.02%. The stock reached an intraday low of CNY 11.65, reflecting ongoing challenges within the company. Over the past week, the stock has decreased by 4.41%, while its performance over the last month shows a modest increase of 6.33%. However, the year-to-date performance remains slightly negative at -0.83%. In terms of longer-term performance, Sichuan Huiyu has faced significant hurdles, with a one-year decline of 27.25%, contrasting sharply with the China Shanghai Composite's gain of 3.56%. The company's financial metrics indicate a concerning trend, with net sales declining at an annual rate of 15.85% and operating profit decreasing by 139.44% over the past five years. Recent half-year results also reflect negative growth, with net sales at CNY 502.7 million, down 17.49%, and net profit at CNY 53.87 million, down 31.32%. With a market capitalization of CNY 7,855 million, Sichuan Huiyu operates within the pharmaceuticals and biotechnology sector, but its financial indicators suggest a challenging environment ahead.